Overview A Study to Evaluate THB001 in Adult Patients With Chronic Cold Urticaria Status: Recruiting Trial end date: 2023-09-01 Target enrollment: Participant gender: Summary This is a phase 1b, open label, non-randomized, sequential dose-escalation, multicenter trial in adult patients with chronic cold urticaria. Phase: Phase 1 Details Lead Sponsor: Third Harmonic Bio, Inc.